ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$155M |
| 2 |
Tesla
TSLA
|
+$142M |
| 3 |
XYZ
Block Inc
XYZ
|
+$110M |
| 4 |
Teladoc Health
TDOC
|
+$44.3M |
| 5 |
Unity
U
|
+$42.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$300M |
| 2 |
Twilio
TWLO
|
+$71.5M |
| 3 |
Fate Therapeutics
FATE
|
+$42.5M |
| 4 |
monday.com
MNDY
|
+$31.1M |
| 5 |
NVIDIA
NVDA
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.93% |
| 2 | Healthcare | 30.35% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Communication Services | 9.7% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tesla
TSLA
$1.21T
| $1.13B | 7.76% |
5,439,635
+814,163
| +18% | +$142M |
|
2
Roku
ROKU
$21.3B
| $822M | 5.65% |
12,483,431
+368,450
| +3% | +$21.6M |
|
3
Zoom
ZM
$26.8B
| $802M | 5.51% |
10,867,033
+251,142
| +2% | +$18.1M |
|
|
4
Coinbase
COIN
$44.2B
| $796M | 5.47% |
11,776,015
+2,586,742
| +28% | +$155M |
|
5
UiPath
PATH
$6.32B
| $788M | 5.42% |
44,891,966
+837,124
| +2% | +$12.6M |
|
|
EXAS
6
DELISTED
Exact Sciences
EXAS
| $772M | 5.3% |
11,379,187
-4,661,303
| -29% | -$300M |
|
|
XYZ
7
Block Inc
XYZ
$49.5B
| $719M | 4.94% |
10,470,931
+1,467,630
| +16% | +$110M |
|
8
Shopify
SHOP
$169B
| $670M | 4.61% |
13,985,791
+706,688
| +5% | +$31.1M |
|
|
9
Teladoc Health
TDOC
$1.69B
| $533M | 3.66% |
20,584,180
+1,655,740
| +9% | +$44.3M |
|
10
DraftKings
DKNG
$12.2B
| $463M | 3.18% |
23,931,255
-1,100,829
| -4% | -$18.3M |
|
|
11
Twilio
TWLO
$29.5B
| $416M | 2.86% |
6,250,001
-1,159,944
| -16% | -$71.5M |
|
12
Roblox
RBLX
$35.4B
| $406M | 2.79% |
9,026,480
+561,670
| +7% | +$21.5M |
|
|
13
Unity
U
$13.9B
| $399M | 2.74% |
12,307,660
+1,335,347
| +12% | +$42.9M |
|
14
Intellia Therapeutics
NTLA
$1.52B
| $367M | 2.52% |
9,837,166
+416,384
| +4% | +$16.3M |
|
15
CRISPR Therapeutics
CRSP
$4.68B
| $361M | 2.48% |
7,990,188
+160,256
| +2% | +$7.78M |
|
16
PagerDuty
PD
$795M
| $344M | 2.36% |
9,830,009
-267,235
| -3% | -$7.85M |
|
17
Pacific Biosciences
PACB
$432M
| $321M | 2.21% |
27,753,679
+2,061,998
| +8% | +$20.5M |
|
18
Robinhood
HOOD
$83.3B
| $308M | 2.12% |
31,734,313
+2,488,889
| +9% | +$23.7M |
|
19
Beam Therapeutics
BEAM
$2.7B
| $263M | 1.8% |
8,573,429
+360,298
| +4% | +$14.2M |
|
20
10x Genomics
TXG
$5.97B
| $232M | 1.59% |
4,155,323
-161,244
| -4% | -$7.53M |
|
21
Ginkgo Bioworks
DNA
$503M
| $219M | 1.51% |
4,118,925
+509,323
| +14% | +$32.3M |
|
22
Veracyte
VCYT
$4.44B
| $188M | 1.29% |
8,409,106
+108,865
| +1% | +$2.63M |
|
|
23
NVIDIA
NVDA
$4.77T
| $115M | 0.79% |
4,143,190
-1,088,620
| -21% | -$23.6M |
|
24
Twist Bioscience
TWST
$5.51B
| $108M | 0.74% |
7,179,112
+478,257
| +7% | +$10.6M |
|
25
Schrodinger
SDGR
$1.14B
| $103M | 0.71% |
3,906,709
+54,672
| +1% | +$1.3M |
|
Similar funds
ARK Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, ARK Investment Management held 238 positions worth $14.6B, up 26% from $11.5B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
ARK Investment Management's Q1 2023 filing shows 6 new, 81 increased, 131 reduced and 17 closed positions. Its largest new stake was Advanced Micro Devices: 186,677 shares worth $18.3M. The largest sale was Exact Sciences, an estimated $300M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- ARK Investment Management's largest Q1 2023 buy was Advanced Micro Devices: 186,677 shares worth $18.3M.
- ARK Investment Management added most to Coinbase in Q1 2023, an estimated $155M increase.
- ARK Investment Management's biggest Q1 2023 reduction was Exact Sciences, cutting an estimated $300M.
- ARK Investment Management fully exited Fate Therapeutics in Q1 2023, selling an estimated $42.5M.
- ARK Investment Management's ten largest holdings make up 52% of its $14.6B portfolio in Q1 2023.
- ARK Investment Management opened 6 new positions and closed 17 in Q1 2023.
- ARK Investment Management's portfolio value rose 26% quarter-over-quarter to $14.6B.
Based on ARK Investment Management's 13F filing for Q1 2023, filed 17 Apr 2023.